NCT06823817

Brief Summary

Colposcopy has become an important link and tool in the prevention and treatment of cervical cancer. The quality and pathological assessment of colposcopy is a key point in follow-up and treatment.The main purpose of this study was to analyze the correlation between colposcopy indications and pathological findings.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

January 25, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 12, 2025

Completed
Last Updated

February 12, 2025

Status Verified

November 1, 2023

Enrollment Period

10 years

First QC Date

January 25, 2025

Last Update Submit

February 8, 2025

Conditions

Cervical CancersCervical Intraepithelial Neoplasia (CIN)

Keywords

Cervical CancersCervical Intraepithelial Neoplasia

Outcome Measures

Primary Outcomes (1)

  • Correlation between colposcopic results and histopathology

    Each enrolled subject had a definite pathological report of cervical biopsy. Investigator analyzed the correlation between cervical cancer screening results and histopathology, and analyzed the overall quality of colposcopy.

    Since this study was a retrospective study, colposcopic biopsy results were available at the time of enrollment. Pathological results were available on average 14 days after colposcopy.

Interventions

colpscopeDIAGNOSTIC_TEST

Colposcopic cervical biopsy

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The outpatient population of our hospital since 2005 10,000 cases are expected to be included.

You may qualify if:

  • at least 18 years of age;
  • Complete colposcopy report;
  • Clear pathological diagnosis was reported after colposcopic biopsy.

You may not qualify if:

  • Under 18 years of age;
  • Lack of colposcopic reports;
  • Lack of cervical biopsy pathology results;
  • Other conditions deemed inappropriate by the investigator to participate in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Uterine Cervical NeoplasmsUterine Cervical Dysplasia

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPrecancerous Conditions

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2025

First Posted

February 12, 2025

Study Start

January 1, 2015

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

February 12, 2025

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share